Showing results (121-130 of 8,864) with videos related to
Sort By:
Pageof 887
Journal of Translational Medicine|January 6, 2011
High expression of transcriptional coactivator p300 correlates with aggressive features and poor prognosis of hepatocellular carcinomaMei Li, Rong-Zhen Luo, Jie-Wei Chen, et al.Journal of Translational Medicine|January 18, 2011
Designed hybrid TPR peptide targeting Hsp90 as a novel anticancer agentTomohisa Horibe, Masayuki Kohno, Mari Haramoto, et al.Journal of Translational Medicine|January 25, 2011
Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals--the Swiss HIV Cohort StudyJan Fehr, Tracy R Glass, Séverine Louvel, et al.Journal of Translational Medicine|October 12, 2010
S110, a novel decitabine dinucleotide, increases fetal hemoglobin levels in baboons (P. anubis)Donald Lavelle, Yogen Saunthararajah, Kestis Vaitkus, et al.Journal of Translational Medicine|April 14, 2011
Rational design of HIV vaccines and microbicides: report of the EUROPRISE network annual conference 2010Sarah Brinckmann, Kelly da Costa, Marit J van Gils, et al.Journal of Translational Medicine|December 2, 2021
Body mass index is not associated with survival outcomes and immune-related adverse events in patients with Hodgkin lymphoma treated with the immune checkpoint inhibitor nivolumabRosaria De Filippi, Fortunato Morabito, Armando Santoro, et al.Journal of Translational Medicine|July 31, 2019
Frequent genetic aberrations in the cell cycle related genes in mucosal melanoma indicate the potential for targeted therapyLongwen Xu, Zhiyuan Cheng, Chuanliang Cui, et al.Journal of Translational Medicine|July 24, 2019
The circulating exosomal microRNAs related to albuminuria in patients with diabetic nephropathyHyoungnae Kim, Yun-Ui Bae, Jin Seok Jeon, et al.Journal of Translational Medicine|August 1, 2019
Loss of the PTCH1 tumor suppressor defines a new subset of plexiform fibromyxomaSudeep Banerjee, Christopher L Corless, Markku M Miettinen, et al.Journal of Translational Medicine|October 26, 2018
Targeted deletion of Insm2 in mice result in reduced insulin secretion and glucose intoleranceLin Wang, Zhong Sheng Sun, Bingwu Xiang, et al.Pageof 887